Abstract

Ethanol provides a rapid, low-cost ablative solution for liver tumors with a small technological footprint but suffers from uncontrolled diffusion in target tissue, limiting treatment precision and accuracy. Incorporating the gel-forming polymer ethyl cellulose to ethanol localizes the distribution. The purpose of this study was to establish a non-invasive methodology based on CT imaging to quantitatively determine the relationship between the delivery parameters of the EC-ethanol formulation, its distribution, and the corresponding necrotic volume. The relationship of radiodensity to ethanol concentration was characterized with water–ethanol surrogates. Ex vivo EC-ethanol ablations were performed to optimize the formulation (n = 6). In vivo ablations were performed to compare the optimal EC-ethanol formulation to pure ethanol (n = 6). Ablations were monitored with CT and ethanol distribution volume was quantified. Livers were removed, sectioned and stained with NADH-diaphorase to determine the ablative extent, and a detailed time-course histological study was performed to assess the wound healing process. CT imaging of ethanol–water surrogates demonstrated the ethanol concentration-radiodensity relationship is approximately linear. A concentration of 12% EC in ethanol created the largest distribution volume, more than eight-fold that of pure ethanol, ex vivo. In vivo, 12% EC-ethanol was superior to pure ethanol, yielding a distribution volume three-fold greater and an ablation zone six-fold greater than pure ethanol. Finally, a time course histological evaluation of the liver post-ablation with 12% EC-ethanol and pure ethanol revealed that while both induce coagulative necrosis and similar tissue responses at 1–4 weeks post-ablation, 12% EC-ethanol yielded a larger ablation zone. The current study demonstrates the suitability of CT imaging to determine distribution volume and concentration of ethanol in tissue. The distribution volume of EC-ethanol is nearly equivalent to the resultant necrotic volume and increases distribution and necrosis compared to pure ethanol.

Highlights

  • Ethanol provides a rapid, low-cost ablative solution for liver tumors with a small technological footprint but suffers from uncontrolled diffusion in target tissue, limiting treatment precision and accuracy

  • The current study demonstrates suitability of computed tomography (CT) imaging to define the delivery and uptake parameters of ECethanol in order to achieve near equivalence of the ethyl cellulose (EC)-ethanol distribution volume to the necrotic volume

  • The equivalency of these two volumes indicates that the distribution volume as determined by ethanol concentration extraction and concentration-based thresholding via CT imaging is an accurate representation of the resultant ablative effect

Read more

Summary

Introduction

Low-cost ablative solution for liver tumors with a small technological footprint but suffers from uncontrolled diffusion in target tissue, limiting treatment precision and accuracy. Thermal ablation is established as a curative treatment for hepatocellular carcinoma (HCC) in the Barcelona Clinic Liver Cancer staging c­ riteria[7]. Compared to surgery it is less ­expensive[8], less ­invasive9, ­faster[10] and requires shorter hospital ­stays[11]. For ethanol ablation to be an effective alternative to thermal ablation, ethanol must be localized within the target ­tissue[18] To achieve this goal in the treatment of venous malformations and herniated discs, ethanol is mixed with the water-insoluble polymer ethyl cellulose (EC) prior to ­injection[19,20]. EC-ethanol ablation reduced tumor volume and was demonstrated as feasible in the treatment of felines with squamous cell ­carcinomas[23]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call